News Overview

Date
Dec 10, 2018

First patient enrolled in a trial for moderate to severe psoriasis

Teaser text We are happy to announce that we have just enrolled the first psoriatic patient in an open-label phase 2a trial, assessing the clinical efficacy and safety of a new, potential treatment. Read more
Date
Oct 30, 2018

Charité – in 2018 again recognised as Germany's best clinic

Teaser text The German journal Focus analysed, reviewed and ranked — for the 7th time in a row — the Charité as the best hospital in Germany. Scores were based on several factors, including the medical and caretaking performance. Read more
Date
Oct 11, 2018

BioJapan 2018 World Business Forum - CRO's in!

Teaser text BioJapan 2018 World Business Forum - BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades. Read more
Date
Aug 14, 2018

Completion of recruitment for a Phase I MS trial

Teaser text Recently we finished recruiting for a Phase I trial in patients with progressive multiple sclerosis. This randomized, double-blind, placebo-controlled study was designed to assess the safety and tolerability of a new biologic as well as the pharmacodynamics...
Read more
Date
Jun 23, 2018

MAD/Phase IIa T2D study publication available

Teaser text As of today you can access a new paper published in The Lancet on 22 June 2018 on a combined multiple-ascending dose (MAD) and Phase IIa study in n=112 patients with controlled type 2 diabetes (HbA1c levels between 6.5–8.5%) via... Read more
Date
Jan 31, 2018

Relocation of Charité Research Organisation's Phase I Unit

Teaser text In January 2018 CRO’s Phase I unit moved from Campus Virchow-Klinikum (CVK) to Campus Mitte at Charité – Universitätsmedizin Berlin. Located at the very heart of Charité’s historic campus, the new facilities underwent extensive modernisation ... Read more
Date
Nov 28, 2017

Phase IIa Sjögren Syndrome Case Study available

Teaser text As of today you can access our first case study that illustrates how - with our help - you can reach Proof of Concept faster. This particular case study deals with a  Phase IIa, single dose, double-blind, placebo-controlled, parallel study to assess the PD, PK ... Read more
Date
Nov 09, 2017

Bacteriophages join the fight against infection

Teaser text (Hannover, Germany) Bacteria worldwide keep developing new resistances to antibiotics. Alternative therapies are urgently needed to meet this challenge. To this end, the Fraunhofer Institute for Toxicology and Experimental ... Read more
Date
Nov 06, 2017

Meet Charité Research at BioEurope 2017

Teaser text Charité Research Organisation will be present at the 2017 BioEurope in Berlin from November 6 to November 8. If you would like to meet, please contact us via enquiries@charite-research.org, +49-30-450 539 211 or the ... Read more